Betmiga 50 mg prolonged-release tablets

Active Ingredient
Strength
  • Mirabegron: 50 mg
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/12/809/008 50 mg G04BD Prolonged-release tablet
EU/1/12/809/009 50 mg G04BD Prolonged-release tablet
EU/1/12/809/010 50 mg G04BD Prolonged-release tablet
EU/1/12/809/011 50 mg G04BD Prolonged-release tablet
EU/1/12/809/012 50 mg G04BD Prolonged-release tablet
EU/1/12/809/013 50 mg G04BD Prolonged-release tablet
EU/1/12/809/014 50 mg G04BD Prolonged-release tablet
Licence number
EU/1/12/809/008
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/009
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/010
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/011
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/012
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/013
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/014
Strength
50 mg
ATC Code
G04BD
Dosage Form
Prolonged-release tablet

Astellas Pharma Co. Ltd

Damastown Road, Damastown Industrial Park, Mulhuddart, Dublin 15